Health Tech, or digital health, helps us understand and take control of our own health. But we also cover more traditional health news like medicines, vaccines and medical procedures.
Researchers in Tanzania have for the first time in Africa created genetically modified mosquitoes that prevent the malaria parasite from developing. The modified mosquitoes contain naturally occurring molecules from frogs and bees that effectively stop the parasite Plasmodium falciparum.
All eight patients with multiple myeloma in two clinical trials had their cancer cells eliminated from the bone marrow. The method could make CAR-T treatment faster and cheaper. Several pharmaceutical companies are now investing in the technology, and more clinical trials are underway.
Patients on the highest dose lost an average of 23.7 percent of their body weight after 68 weeks. The drug also reduced knee arthritis pain by up to 62.6 percent. More than one in eight patients who took the drug became completely free of knee pain by the end of the trial.
Researchers have developed a capsule with bacteria that is swallowed, detects bleeding in the gut, and can then be easily collected from stool using a magnet. The entire process from collection to analysis takes about 25 minutes.
A five-in-one vaccine has begun to be used in several African countries to protect against bacterial meningitis. The vaccine costs only three dollars per dose and protects against four types of bacteria that cause almost all meningitis epidemics in the region.
A blood test shows ability to identify over 50 different cancer types and can speed up diagnosis. More than half of the cancer forms were detected in early stages where treatment is more effective. Three-quarters of the detected cancer types currently lack screening programs.
A single gene therapy using patients' own stem cells has cured 95 percent of treated children with a deadly immune disorder. The treatment uses the patient's own stem cells that are genetically modified to produce the missing enzyme.
AI models have designed 16 working viruses that can attack E. coli bacteria in the laboratory. The development of the technology could lead to new treatments against antibiotic-resistant bacterial infections.
Nearly 98 percent of patients with prostate cancer are alive at least five years after diagnosis in 2021.